Future perspective for delivery of antiretroviral drugs | David Back, PhD

Rio de Janeiro HIV Clinical Forum 2018

Simplified regimens: pros and cons | Pedro Cahn, MD, PhD

Rio de Janeiro HIV Clinical Forum 2018

Clinical case presentation | Tânia Vergara, MD, PhD

Rio de Janeiro HIV Clinical Forum 2018

Optimal use of INSTI’s in routine practice | Carlos Brites, MD, PhD

Rio de Janeiro HIV Clinical Forum 2018

SIERJ SESSION: Is early ART for everyone? | Mauro Schechter, MD, PhD

Rio de Janeiro HIV Clinical Forum 2018

Clinical case presentation | Marcio de Figueiredo Fernandes, MD

Rio de Janeiro HIV Clinical Forum 2018

HIV prevention and the role of integrase inhibitors | Pep Coll, MD

Rio de Janeiro HIV Clinical Forum 2018

INSTIs in women and pregnancy | Sharon Walmsley, FRCPC, MD, MSC

Rio de Janeiro HIV Clinical Forum 2018

DDIs, INSTIs, TB and hepatitis | David Back, PhD

Rio de Janeiro HIV Clinical Forum 2018

Transmitted resistance to ARVs and its impact on initial therapy | Ricardo Diaz, MD

Rio de Janeiro HIV Clinical Forum 2018

Resistance to Integrase Inhibitors | Charles Boucher, MD, PhD

Rio de Janeiro HIV Clinical Forum 2018